Drugs / DAR-100A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT01519557 | Apr 2011 → Aug 2013 | schizoaffective disorder, schizophrenia | New York State Psychiatric Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DAR-100A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01519557 ↗ |
| Route | Intravenous | “15mg or 0.5mg of DAR-100A intravenously over 30 minutes for 5 days, 9 days off then again for 5 more days” NCT01519557 ↗ |